Gundlach Nets $1 Billion For First Hedge Fund

Jun 28 2010 | 7:21am ET

Hedge fund DoubleLine Capital, founded by former TCW Group chief investment officer Jeffrey Gundlach, has raised more than $1 billion for its maiden fund less than three months after its launch.

Gundlach serves as co-manager of the Total Return Bond Fund, which invests primarily in mortgage-backed securities. The fund debuted on April 6.

“The raising of more than $1 billion in the DoubleLine Total Return Bond Fund within its first quarter of operations marks a significant milestone,” Ron Redell, president of the DoubleLine Funds Trust, said.

Gundlach founded Los Angeles-based DoubeLine after leaving TCW last year. TCW has accused Gundlach and DoubleLine of breach of contract and fiduciary duty, unfair competition and conspiracy. The firm also claims that, after it fired Gundlach, it found marijuana, drug paraphernalia and a variety of “hardcore” pornography and “sexual devices” in his office. Gundlach has since countersued.


In Depth

Change In 'Accredited Investor' Definition Could Hurt Crowdfunding Space

Jul 25 2014 | 8:14am ET

The Securities and Exchange Commission is considering changes to its 30-year-old...

Lifestyle

David Yarrow On Growing His Hedge Fund And Shooting The Animals And People Of Africa - As A Photographer

Jul 23 2014 | 6:44am ET

While he’s always been a photographer, recent expeditions to Iceland, Ethiopia...

Guest Contributor

The Truth About Track Record Portability

Jul 24 2014 | 5:55am ET

The number of private funds converting to mutual funds has increased significantly...

 

Sponsored Content

    Northern Trust Helps Hedge Funds Navigate Derivatives Regulations

    Jul 8 2014 | 10:48am ET

    The surge in derivatives regulation is among the most complex challenges facing the financial services industry today. Northern Trust’s Joshua Satten recently spoke with FINalternatives to share insights into the challenges presented by new regulation and explore how the industry is responding. Read more…

Publisher's Note